Coronary disease & ACS

Guiding Intervention for Complex Coronary Lesions by Optical Coherence Tomography or Intravascular Ultrasound

J Am Coll CardiolPublished Secondary analysis of the OCTIVUS randomised trial

Primary result · Complex coronary lesions subgroupResult — go to the resultHazard ratio 0.87 95% CI 0.59–1.29

Authors' conclusion

Among patients with complex coronary artery lesions, OCT-guided PCI showed a similar risk of primary composite event of death from cardiac causes, target vessel-related myocardial infarction, or target vessel revascularization as compared with IVUS-guided PCI.

Study context

Population
Patients undergoing imaging-guided percutaneous coronary intervention (PCI) for complex coronary artery lesions (unprotected left main, bifurcation, aorto-ostial, chronic total occlusion, severely calcified, in-stent restenotic, diffuse long lesion, or multivessel PCI)of 2,008 randomized
Participants
1,475 patients
Comparison
Optical coherence tomography (OCT)-guided vs intravascular ultrasound (IVUS)-guided PCI
  • OCT-guidedn = 719
  • IVUS-guidedn = 756reference
Primary endpoint
Composite of:
  • Cardiac death
  • Target vessel-related MI
  • Ischemia-driven target vessel revascularization
Follow-up
Median 2.0 years
Methodological detailsprespecified subgroup analysis
  • Prespecified subgroup analysis

Primary result

Complex coronary lesions subgroup

Hazard ratio

0.87

95% CI 0.59–1.29

P = 0.50

Events by treatment group

OCT-guidedvs IVUS-guided
HR 0.87 (95% CI 0.59–1.29); P = 0.50

As reported in the abstract

Safety

Major procedural complications · lower with OCT-guided

P = 0.03

Contrast-induced nephropathy

Similar between the 2 groups (1.9% vs 1.5%)
P = 0.46

Original publication

Guiding Intervention for Complex Coronary Lesions by Optical Coherence Tomography or Intravascular Ultrasound. J Am Coll Cardiol. Published 23 October 2023. doi:10.1016/j.jacc.2023.10.017

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.